TY - JOUR
T1 - Reagentless impedimetric immunosensor for monitoring of methotrexate in human blood serum using multiwalled carbon nanotube@polypyrrole/polytyramine film electrode
AU - Adeniyi, K.O.
AU - Osmanaj, Blerina
AU - Manavalan, Gopinathan
AU - Mikkola, Jyri-Pekka
AU - Berisha, Avni
AU - Tesfalidet, Solomon
N1 - © 2023 The Authors
PY - 2024/2/1
Y1 - 2024/2/1
N2 - Ensuring effective monitoring of methotrexate (MTX) levels in the bloodstream of cancer patients undergoing high-dose methotrexate chemotherapy is crucial to prevent potentially harmful side effects. However, the absence of portable analytical devices suitable for point-of-care bedside monitoring has presented a significant obstacle to achieving real-time MTX monitoring. In this study, we developed an impedimetric immunosensor that doesn't require reagents for measuring MTX levels in undiluted human blood serum. This reagentless approach simplifies the assay process, enabling rapid and straightforward MTX quantification. The immunosensor transducer was fabricated by electrodepositing conductive network of porous multiwalled carbon nanotube@polypyrrole/polytyramine on screen-printed gold microchip electrode (SP–Au/MWCNT
70@PPy-PTA). Polyclonal anti-MTX antibodies were immobilized on the film, acting as the immunorecognition element. Non-specific binding was prevented by blocking the transducer interface with denatured bovine serum albumin (
dBSA) fibrils, resulting in SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA film electrode. When MTX binds to the SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA interface, the film conductance and electron transfer resistance changes. This conductivity attenuation allows for electrochemical impedimetric signal transduction without a redox-probe solution. The electrochemical impedance spectroscopy (EIS) results showed increased charge transfer resistance and phase angle as MTX concentrations increased. The SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA demonstrated high sensitivity, with a linear response from 0.02 to 20.0 μM and a detection limit of 1.93 nM. The detection limit was 50 times lower than the intended safe level of MTX in human serum. The immunosensor exhibited minimal cross-reactivity with endogenous MTX analogs and serum proteins. The SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA immunosensor presents a simple and rapid method for therapeutic drug monitoring compared to traditional immunoassay systems.
AB - Ensuring effective monitoring of methotrexate (MTX) levels in the bloodstream of cancer patients undergoing high-dose methotrexate chemotherapy is crucial to prevent potentially harmful side effects. However, the absence of portable analytical devices suitable for point-of-care bedside monitoring has presented a significant obstacle to achieving real-time MTX monitoring. In this study, we developed an impedimetric immunosensor that doesn't require reagents for measuring MTX levels in undiluted human blood serum. This reagentless approach simplifies the assay process, enabling rapid and straightforward MTX quantification. The immunosensor transducer was fabricated by electrodepositing conductive network of porous multiwalled carbon nanotube@polypyrrole/polytyramine on screen-printed gold microchip electrode (SP–Au/MWCNT
70@PPy-PTA). Polyclonal anti-MTX antibodies were immobilized on the film, acting as the immunorecognition element. Non-specific binding was prevented by blocking the transducer interface with denatured bovine serum albumin (
dBSA) fibrils, resulting in SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA film electrode. When MTX binds to the SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA interface, the film conductance and electron transfer resistance changes. This conductivity attenuation allows for electrochemical impedimetric signal transduction without a redox-probe solution. The electrochemical impedance spectroscopy (EIS) results showed increased charge transfer resistance and phase angle as MTX concentrations increased. The SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA demonstrated high sensitivity, with a linear response from 0.02 to 20.0 μM and a detection limit of 1.93 nM. The detection limit was 50 times lower than the intended safe level of MTX in human serum. The immunosensor exhibited minimal cross-reactivity with endogenous MTX analogs and serum proteins. The SP-Au/MWCNT
70@PPy-PTA/anti-MTX
Ab|
dBSA immunosensor presents a simple and rapid method for therapeutic drug monitoring compared to traditional immunoassay systems.
KW - Carbon nanotube network
KW - Electrochemical impedance spectroscopy
KW - Methotrexate
KW - Reagentless sensor
KW - Therapeutic drug monitoring
UR - http://www.scopus.com/inward/record.url?scp=85174487495&partnerID=8YFLogxK
U2 - 10.1016/j.talanta.2023.125316
DO - 10.1016/j.talanta.2023.125316
M3 - Article
C2 - 37864856
SN - 0039-9140
VL - 268
JO - Talanta
JF - Talanta
IS - 1
M1 - 125316
ER -